[1] |
CAO Fei, YU Wenhao, TANG Xiaonan, MA Zidong, CHANG Tingmin, GONG Yabin, LIAO Mingjuan, KANG Xiaohong.
Mechanism of LINC01410 promoting proliferation and migration in esophageal squamous cell carcinoma
[J]. China Oncology, 2024, 34(8): 753-762.
|
[2] |
Urologic Chinese Oncology Group.
Expert consensus on early diagnosis and treatment of bladder cancer (2024 edition)
[J]. China Oncology, 2024, 34(6): 607-618.
|
[3] |
YE Junling, ZHENG Xiaoying, GUO Xinjian, CHEN Ruihui, YANG Liu, GOU Xiaodan, JIANG Hanmei.
A study on mechanism of lncRNA-mediated SNHG5/miR-26a-5p/MTDH signal axis promoting metastasis of colorectal cancer
[J]. China Oncology, 2023, 33(7): 673-685.
|
[4] |
WANG Xuemei, CHENG Yu, QI Jiemin.
PRMT7 inhibits proliferation and migration of bladder cancer cells by regulating Notch signaling pathway
[J]. China Oncology, 2023, 33(5): 437-444.
|
[5] |
TANG Duocai, ZHOU Shukui, ZHANG Guiyin, LIU Lei, LIAO Hong.
Analysis of risk factors of recurrence in non-muscle invasive bladder cancer patients after initial transurethral resection of bladder tumor
[J]. China Oncology, 2023, 33(5): 478-483.
|
[6] |
ZHENG Shengfeng, ZHU Yiping, YE Dingwei.
Advances in basic research, clinical diagnosis and treatment of bladder cancer in 2022
[J]. China Oncology, 2023, 33(3): 201-209.
|
[7] |
CHEN Ruchuan, LIU Wei, ZHOU Bingni, LIU Xiaohang, ZHOU Liangping.
The value of VI-RADS combined with tumor contact length in the detection of muscle-invasive bladder cancer
[J]. China Oncology, 2023, 33(3): 260-266.
|
[8] |
HU Keshu, LIU Wenfeng, ZHANG Feng, QUAN Bing, YIN Xin.
Mechanism of LINC00601 in regulating sensitivity of hepatocellular carcinoma cells to oxaliplatin chemotherapy
[J]. China Oncology, 2023, 33(1): 25-35.
|
[9] |
CHEN Anli, SHEN Haoyuan, YANG Shixiong, DENG Chunyan, HU Chaohua, LIU Hanzhong, WANG Shu, QIAN Fang.
Predictive value of plasma long non-coding RNA H19 in neoadjuvant therapy for breast cancer
[J]. China Oncology, 2022, 32(8): 727-735.
|
[10] |
LIAO Xinghe, LIU Zhantao, LIU Minghui.
Glioma stem cell-derived exosomal lncRNA HOXA-AS2 promoted proliferation, migration, invasion and stemness in glioma
[J]. China Oncology, 2022, 32(12): 1218-1228.
|
[11] |
XU Wenhao, TIAN Xi, Aihetaimujiang·Anwaier , QU Yuanyuan, SHI Guohai, ZHANG Hailiang, YE Dingwei.
A systematic review of current advancements of artificial intelligence in genitourinary cancers
[J]. China Oncology, 2022, 32(1): 68-74.
|
[12] |
JIN Youping, LI Luying, ZHOU Ping.
A study on the role of long non-coding RNA STMN1P2 in breast cancer and its mechanism
[J]. China Oncology, 2021, 31(7): 596-604.
|
[13] |
SHI Wanhong , ZOU Lei , KANG Qiang , WANG Junfeng , BAI Jianhua , JIN Yun , ZHANG Jie , ZHANG Xiaowen .
The influence of silencing leptin gene on the invasion and migration abilities of gallbladder cancer GBC-SD and OCUG cells
[J]. China Oncology, 2021, 31(11): 1050-1057.
|
[14] |
ZHANG Lianglong , AN Hongwei , ZHAO Lizhi , DONG Qian , GAO Guiyan .
Mechanism of overexpression of lncRNA LINC00152 in temozolomide-induced stem cell cycle arrest in glioma
[J]. China Oncology, 2020, 30(5): 328-334.
|
[15] |
HE Chunfeng, ZHANG Qingchuan, LIU Yong.
Silencing rictor gene by RNA interference inhibits cell growth of human bladder cancer T24 in vitro and in vivo
[J]. China Oncology, 2019, 29(3): 193-200.
|